amsacrine (Compound)

Synonyms:amsacrine, 51264-14-3, Amsidine, m-AMSA, Amsidyl, Acridinylanisidide, Lamasine, Amekrin, Amsacrina, mAMSA

Pubchem:PUBCHEM:3926765

Id:77659382-ef5f-5ad1-b81d-36e6b1d7984d

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View amsacrine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for amsacrine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with amsacrine.

Results found

Linked to

	Label	Description
	amsacrine negatively regulates DEPDC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	amsacrine positively regulates ATF3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	amsacrine (ef1444bc-884f-412c-820f-c6589aeb92d2) Collection (Entity type)	Metadatata for amsacrine
	DCSTRUCT ID 00203 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00203; PubChem_CID:2179, FILE=drugcentral_drug_00203.json)
	Gemcitabine in similarity relationship with amsacrine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(3-(5-iodo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide in similarity relationship with amsacrine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID11114140 in similarity relationship with amsacrine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	amsacrine negatively regulates BUB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	amsacrine negatively regulates DLGAP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	amsacrine positively regulates CXADR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

amsacrine negatively regulates DEPDC1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

amsacrine positively regulates ATF3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

amsacrine (ef1444bc-884f-412c-820f-c6589aeb92d2)

Collection (Entity type)

Metadatata for amsacrine

DCSTRUCT ID 00203

Collection (Entity type)

DrugPage Collection: (DrugCentralID:00203; PubChem_CID:2179, FILE=drugcentral_drug_00203.json)

Gemcitabine in similarity relationship with amsacrine

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

N-(3-(5-iodo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide in similarity relationship with amsacrine

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

SID11114140 in similarity relationship with amsacrine

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

amsacrine negatively regulates BUB1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

amsacrine negatively regulates DLGAP5

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

amsacrine positively regulates CXADR

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.